These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 23383697

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation.
    Fujisawa M, Iijima K, Ishimura T, Higuchi A, Isotani S, Yoshiya K, Arakawa S, Hamami G, Matsumoto O, Yoshikawa N, Kamidono S.
    Pediatr Nephrol; 2002 Mar; 17(3):165-8. PubMed ID: 11956852
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 25. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 26. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A.
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [Abstract] [Full Text] [Related]

  • 27. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation.
    Apeland T, Hartmann A.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2091-4. PubMed ID: 18319357
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 Jun; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

  • 32. Long-term outcome of renal transplantation in focal glomerulosclerosis.
    Akioka K, Okamoto M, Wakabayashi Y, Nobori S, Ogino S, Ushigome H, Uryuhara K, Kaihara S, Yoshimura N.
    Transplant Proc; 2006 Nov; 38(9):2819-22. PubMed ID: 17112838
    [Abstract] [Full Text] [Related]

  • 33. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
    Gulati S, Kher V.
    Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
    [Abstract] [Full Text] [Related]

  • 34. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 35. Recurrent focal glomerulosclerosis: natural history and response to therapy.
    Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F.
    Am J Med; 1992 Apr; 92(4):375-83. PubMed ID: 1558084
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
    Seso Simić D, Slavicek J, Bubić Filipi L, Puretić Z, Kes P.
    Acta Med Croatica; 2003 Apr; 57(1):53-6. PubMed ID: 12876864
    [Abstract] [Full Text] [Related]

  • 38. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
    Turk J Pediatr; 2010 Apr; 52(3):255-61. PubMed ID: 20718182
    [Abstract] [Full Text] [Related]

  • 39. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD.
    Transplantation; 2009 Apr 27; 87(8):1232-9. PubMed ID: 19384172
    [Abstract] [Full Text] [Related]

  • 40. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.
    Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.
    Transplantation; 2017 Mar 27; 101(3):649-656. PubMed ID: 27043407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.